Introducing a new trait into a crop through conventional breeding commonly takes decades, but recently developed genome sequence modification technology has the potential to accelerate this process. One of these new breeding technologies relies on an RNA-directed DNA nuclease (CRISPR/Cas9) to cut the genomic DNA, in vivo, to facilitate the deletion or insertion of sequences. This sequence specific targeting is determined by guide RNAs (gRNAs). However, choosing an optimum gRNA sequence has its challenges. Almost all current gRNA design tools for use in plants are based on data from experiments in animals, although many allow the use of plant genomes to identify potential off-target sites. Here, we examine the predictive uniformity and performance of eight different online gRNA-site tools. Unfortunately, there was little consensus among the rankings by the different algorithms, nor a statistically significant correlation between rankings and in vivo effectiveness. This suggests that important factors affecting gRNA performance and/or target site accessibility, in plants, are yet to be elucidated and incorporated into gRNA-site prediction tools.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980586PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0227994PLOS

Publication Analysis

Top Keywords

current grna
8
grna ranking
4
ranking prediction
4
prediction algorithms
4
algorithms genome
4
genome editing
4
editing plants?
4
plants? introducing
4
introducing trait
4
trait crop
4

Similar Publications

Background: The recent success of a population control gene drive targeting the doublesex gene in Anopheles gambiae paved the way for developing self-sustaining and self-limiting genetic control strategies targeting the sex determination pathway to reduce and/or distort the reproductive capacity of insect vectors. However, targeting these genes for genetic control requires a better understanding of their genetic variation in natural populations to ensure effective gene drive spread. Using whole genome sequencing (WGS) data from the Ag1000G project (Ag3.

View Article and Find Full Text PDF

Asymmetric CRISPR-Cas12a powered electrochemical aptasensor for clenbuterol detection based on competitive gRNA mediated cascade signal amplification.

Food Chem

February 2025

College of New Energy Materials and Chemistry, Leshan Normal University, Leshan, Sichuan 614000, PR China. Electronic address:

The residue of clenbuterol (CLB) in food poses a potential harm to human health. Herein, we presented an electrochemical aptasensor (E-A-CRISPR) based on employing an aptamer as a specific recognition element and asymmetric CRISPR-Cas12a as signal amplifiers for sensitive, and selective detection of CLB. In this E-A-CRISPR system, the target CLB bound to the aptamer and initiated cascade signal amplification through the DNase activity of CRISPR-Cas12a with two competitive gRNAs.

View Article and Find Full Text PDF

Correction of Griscelli Syndrome Type 2 causing mutations in the gene with CRISPR/Cas9.

Turk J Biol

July 2024

Department of Stem Cell Sciences, Center for Stem Cell Research and Development, Graduate School of Health Sciences, Hacettepe University, Ankara, Turkiye.

Background/aim: Griscelli Syndrome Type 2 (GS-2) is a rare, inherited immune deficiency caused by a mutation in the gene. The current treatment consists of hematopoietic stem cell transplantation, but a lack of suitable donors warrants the development of alternative treatment strategies, including gene therapy. The development of mutation-specific clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 gene editing technology has opened the way for custom-designed gene correction of patient-derived stem cells.

View Article and Find Full Text PDF

Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy.

Molecules

October 2024

Department of Chemistry and the Natural Science Research Institute, Myongji University, 116 Myongji-ro, Yongin-si 17058, Republic of Korea.

Nucleic acid therapeutics are promising alternatives to conventional anti-cancer therapy, such as chemotherapy and radiation therapy. While conventional therapies have limitations, such as high side effects, low specificity, and drug resistance, nucleic acid therapeutics work at the gene level to eliminate the cause of the disease. Nucleic acid therapeutics treat diseases in various forms and using different mechanisms, including plasmid DNA (pDNA), small interfering RNA (siRNA), anti-microRNA (anti-miR), microRNA mimics (miRNA mimic), messenger RNA (mRNA), aptamer, catalytic nucleic acid (CNA), and CRISPR cas9 guide RNA (gRNA).

View Article and Find Full Text PDF

Be-dataHIVE: a base editing database.

BMC Bioinformatics

October 2024

Department of Computer Science, University of Oxford, Parks Road, Oxford, OX1 3QD, UK.

Article Synopsis
  • - Base editing is a precise gene editing technique focused on transforming individual nucleotides to potentially cure rare diseases, but its design process is labor-intensive and unpredictable, requiring accuracy and efficiency for clinical applications.
  • - Recent developments in computational models aim to predict base editing outcomes, but these models lack robustness due to the absence of a comprehensive, diverse dataset.
  • - To address this gap, BE-dataHIVE was created as a mySQL database with over 460,000 gRNA target combinations and data from five studies, providing valuable resources for machine learning and accessibility for researchers via a website and API.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!